Biotech

All Articles

Editas cashes in on Vertex Cas9 licensing legal rights for $57M

.Versus the scenery of a Cas9 patent battle that refuses to die, Editas Medication is moneying in a ...

Ultragenyx fine-tunes gene therapy application to call up effectiveness

.A minority of patients taking Ultragenyx Drug's Wilson health condition gene treatment UX701 have c...

Biopharma discharge price stabilizes in Q3: Ferocious Biotech evaluation

.As summer heat energy turns to cool down winds, hopes that this year would certainly take prevalent...

J &amp J falls period 2 dengue prospect in most current switch from vaccines

.Johnson &amp Johnson's deprioritization of its own transmittable disease pipeline has actually asse...

Relay loses 10% of workers after earlier layoffs in July

.Preciseness medicine biotech Relay Rehabs is actually shedding around 10% of its labor force in att...

Pentixapharm scores $22M IPO to advance radiopharma tests

.Pentixapharm has actually produced just about twenty thousand europeans ($ 22 thousand) from an IPO...

Lundbeck touches Charles River for AI-enabled neuro medication invention

.Lundbeck has used Charles River Laboratories' expert system abilities to help the invention of neur...

Big pharma, biotech 'won't essentially be cooperative' in artificial intelligence: S&ampP

.Huge Pharma is putting in highly in AI to lower growth timetables and also foster development. But ...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Biography has roped in $115 million in collection B funds to advance preclinical antitoxin ...

IGM pivots from cancer to autoimmune, shaking up C-suite

.IGM Biosciences finished in 2014 laying off workers as well as enhancing its own cancer pipe. Now, ...